Ace inhibitor-induced cough in hypertensive type 2 diabetic patients [3]

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1586-1587

  Malini, Pier Luigi ^a   Strocchi, Enrico ^a   Fiumi, Nicoletta ^a   Ambrosioni, Ettore ^a   Ciavarella, Adolfo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; COUGHING; DRUG EFFECT; HUMAN; HYPERTENSION; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COUGH; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; MALE;

EID: 0032870335     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1586     Document Type: Letter

References (4)

1. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 117:234-242, 1992
2. Strocchi E, Malini PL, Valtancoli G, Ricci C, Bassein L, Ambrosioni E: Cough during treatment with angiotensin-converting enzyme inhibitors: analysis of predisposing factors. Drug Invest 4:69-72, 1992
3. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317:713-720, 1998
4. Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E: Thromboxane antagonism and cough induced by angiotensin-converting enzyme inhibitor. Lancet 350: 15-18, 1997